Dr. Makary argues for more humility from the medical establishment and common sense when reviewing experimental drugs for ...
One of the most highly anticipated FDA decisions this month is for Alnylam Pharmaceuticals, which is seeking to expand the ...
There may be more bad products on the shelves,” one FDA scientist warnsBy Lauren KirchnerMany critical functions of the food ...
Chemicals such as titanium dioxide and potassium bromate, whose safety has been debated, are allowed in foods in the United ...
3don MSN
President Donald Trump’s pick to lead the US Food and Drug Administration told senators in a tense confirmation hearing ...
Medical device maker Dexcom said it has received a warning letter from the U.S. Food and Drug Administration following ...
WASHINGTON — President Donald Trump’s nominee to lead the Food and Drug Administration refused to commit to keeping access to ...
In particular, AI could assist FDA staff to review drug and device applications, he told senators on the Health, Education, ...
DexCom received a warning letter from the Food and Drug Administration following inspections of its San Diego and Mesa, Ariz.
For communications leaders across industries, this initiative underscores the critical importance of crafting clear messaging ...
Dr. Marty Makary is largely sidestepping Senate questions about his plans to lead the Food and Drug Administration ...
As part of its enforcement activities, the Food and Drug Administration sends warning letters to entities under its jurisdiction. Some letters are not ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results